These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 943089)

  • 21. Role of the antiglucocorticoid RU 486 in the prevention of steroid-induced hypertension.
    Opoku J; Kalimi M
    Acta Endocrinol (Copenh); 1992 Sep; 127(3):258-61. PubMed ID: 1414152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deoxycorticosterone acetate-salt rats: hypertension and sympathoexcitation driven by increased NaCl levels.
    O'Donaughy TL; Brooks VL
    Hypertension; 2006 Apr; 47(4):680-5. PubMed ID: 16520400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NaCl appetite in two strains of rat reported to be resistant to mineralocorticoid-induced hypertension.
    Rowland NE
    Physiol Behav; 1998 Apr; 64(1):49-56. PubMed ID: 9661981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats.
    Watts SW; Fink GD
    Am J Physiol; 1999 Mar; 276(3):H944-52. PubMed ID: 10070078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overflow of endogenous norepinephrine from PVH nucleus of DOCA-salt hypertensive rats.
    Qualy JM; Westfall TC
    Am J Physiol; 1995 Apr; 268(4 Pt 2):H1549-54. PubMed ID: 7733356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of hypertension in animals with reduced total peripheral resistance.
    Huang M; Hester RL; Coleman TG; Smith MJ; Guyton AC
    Hypertension; 1992 Dec; 20(6):828-33. PubMed ID: 1452299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased release of atrial natriuretic polypeptides in rats with DOCA-salt hypertension.
    Sugimoto T; Ishii M; Hirata Y; Matsuoka H; Sugimoto T; Miyata A; Toshimori T; Masuda H; Kangawa K; Matsuo H
    Life Sci; 1986 Apr; 38(15):1351-8. PubMed ID: 2937987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats.
    Pham I; el Amrani AI; Fournié-Zaluski MC; Corvol P; Roques B; Michel JB
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):847-57. PubMed ID: 1282584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelin-A receptor blockade prevents left ventricular hypertrophy and dysfunction in salt-sensitive experimental hypertension.
    Rothermund L; Vetter R; Dieterich M; Kossmehl P; Gögebakan O; Yagil C; Yagil Y; Kreutz R
    Circulation; 2002 Oct; 106(18):2305-8. PubMed ID: 12403658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of inhibiting brain reactive oxygen species on sympathetic nerve activity in DOCA-salt hypertensive rats].
    Zhang Q; Tan Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Nov; 34(11):1632-6. PubMed ID: 25413063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baroreflex sensitivity and susceptibility to systolic hypertension induced by DOCA-salt in the Sabra rat.
    Weinstock M; Schorer-Apelbaum D; Ben-Ishay D
    Am J Physiol; 1984 Mar; 246(3 Pt 2):H448-52. PubMed ID: 6703079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelium-derived relaxing factor responses in Doca-salt hypertensive rats.
    Kirchner KA; Scanlon PH; Dzielak DJ; Hester RL
    Am J Physiol; 1993 Sep; 265(3 Pt 2):R568-72. PubMed ID: 8214147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
    Rahmouni K; Sibug RM; De Kloet ER; Barthelmebs M; Grima M; Imbs JL; De Jong W
    Eur J Pharmacol; 2002 Feb; 436(3):207-16. PubMed ID: 11858800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitivity of caudal arteries and the mesenteric vascular bed to norepinephrine in DOCA-salt hypertension.
    Longhurst PA; Rice PJ; Taylor DA; Fleming WW
    Hypertension; 1988 Aug; 12(2):133-42. PubMed ID: 3410523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of eicosanoids on renal function of DOCA-salt hypertensive rats.
    Roman RJ; Kaldunski ML; Mattson DL; Mistry M; Nasjletti A
    Hypertension; 1988 Sep; 12(3):287-94. PubMed ID: 3169943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-dependent DOCA-salt hypertension in Brattleboro rats: the role of vasopressin.
    Zicha J; Kunes J; Jelínek J
    Physiol Bohemoslov; 1987; 36(1):33-42. PubMed ID: 2954169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lithium prevents saline deoxycorticosterone acetate (DOCA) hypertension in the rat.
    Iaina A; Shochat J; Serban I; Kapuler S; Gavendo S; Goldfarb D; Eliahou HE
    J Lab Clin Med; 1982 Feb; 99(2):231-8. PubMed ID: 6278037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of endothelin on resistance arteries of DOCA-salt hypertensive rats.
    Deng LY; Schiffrin EL
    Am J Physiol; 1992 Jun; 262(6 Pt 2):H1782-7. PubMed ID: 1621836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppressive effect of sulfate on the development of hypertension in DOCA-salt hypertensive rats.
    Kubota Y; Sano H; Kawahara J; Hattori K; Miki T; Suzuki H; Fukuzaki H
    Am J Hypertens; 1991 Feb; 4(2 Pt 1):169-72. PubMed ID: 2021448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of increase in concentrations of cerebrospinal fluid sodium in rats with various stages of DOCA-salt hypertension.
    Takata Y; Yamashita Y; Takishita S; Fujishima M
    Life Sci; 1988; 42(12):1223-9. PubMed ID: 3347147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.